Bioactive Gelatin-based Date By-Product for Packaging Applications: Physico-Chemical and Biological Characterization

 Biodegradable films from gelatin (Gn) with various date by-product (DBP) concentrations (1, 2, 3 and 4 wt %) were prepared. Elaborated films were examined in terms of physical properties (thickness, density, water solubility, water content, degree of swelling, color), and antimicrobial properties (Escherichia coli and Staphylcoccus aureus). Adding the highest concentration of DBP (4%), resulted an increase in the WHC of film as compared with control film. Moreover, the incorporation of 1% DBP reduced the moisture level of Gn based composite films as compared with the control film. Furthermore, Film with 4% of DBP had the lowest solubility which reached 39.39%. Incorporation of DBP from 1 to 4% showed decrease of L- and a-values. The active Gn-DBP 1% showed less lightness as compared to Gn-DBP 3%. The incorporation of DBP into film-forming solutions led to increased opaqueness for all gelatin-based composite films. The calculated opacity value was inversely proportional to transparency. Moreover, the Active Gn-DBP 1% and 2% film presented effective antibacterial activity against bacteria such as Staphylococcus aureus and Escherichia coli. The results showed an enhancement in the biodegradability of Gn-DBP films in moist soil. The results reveal the benefits of date by-products incorporated into gelatin based films as a potential material for active food packaging.&nbsp

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

International audienceThe aim of this study was to estimate the incidence of COVID-19 disease in the French national population of dialysis patients, their course of illness and to identify the risk factors associated with mortality. Our study included all patients on dialysis recorded in the French REIN Registry in April 2020. Clinical characteristics at last follow-up and the evolution of COVID-19 illness severity over time were recorded for diagnosed cases (either suspicious clinical symptoms, characteristic signs on the chest scan or a positive reverse transcription polymerase chain reaction) for SARS-CoV-2. A total of 1,621 infected patients were reported on the REIN registry from March 16th, 2020 to May 4th, 2020. Of these, 344 died. The prevalence of COVID-19 patients varied from less than 1% to 10% between regions. The probability of being a case was higher in males, patients with diabetes, those in need of assistance for transfer or treated at a self-care unit. Dialysis at home was associated with a lower probability of being infected as was being a smoker, a former smoker, having an active malignancy, or peripheral vascular disease. Mortality in diagnosed cases (21%) was associated with the same causes as in the general population. Higher age, hypoalbuminemia and the presence of an ischemic heart disease were statistically independently associated with a higher risk of death. Being treated at a selfcare unit was associated with a lower risk. Thus, our study showed a relatively low frequency of COVID-19 among dialysis patients contrary to what might have been assumed